Significance Associated with Phenotype Score Aids in Variant Prioritization for Exome Sequencing Analysis

IF 3.4 3区 医学 Q1 PATHOLOGY
Brian Lee , Lily Nasanovsky , Lishuang Shen , Dennis T. Maglinte , Yachen Pan , Xiaowu Gai , Ryan J. Schmidt , Gordana Raca , Jaclyn A. Biegel , Megan Roytman , Paul An , Carol J. Saunders , Emily G. Farrow , Soheil Shams , Jianling Ji
{"title":"Significance Associated with Phenotype Score Aids in Variant Prioritization for Exome Sequencing Analysis","authors":"Brian Lee ,&nbsp;Lily Nasanovsky ,&nbsp;Lishuang Shen ,&nbsp;Dennis T. Maglinte ,&nbsp;Yachen Pan ,&nbsp;Xiaowu Gai ,&nbsp;Ryan J. Schmidt ,&nbsp;Gordana Raca ,&nbsp;Jaclyn A. Biegel ,&nbsp;Megan Roytman ,&nbsp;Paul An ,&nbsp;Carol J. Saunders ,&nbsp;Emily G. Farrow ,&nbsp;Soheil Shams ,&nbsp;Jianling Ji","doi":"10.1016/j.jmoldx.2024.01.009","DOIUrl":null,"url":null,"abstract":"<div><p>Several <em>in silico</em> annotation-based methods have been developed to prioritize variants in exome sequencing analysis. This study introduced a novel metric Significance Associated with Phenotypes (SAP) score, which generates a statistical score by comparing an individual's observed phenotypes against existing gene–phenotype associations. To evaluate the SAP score, a retrospective analysis was performed on 219 exomes. Among them, 82 family-based and 35 singleton exomes had at least one disease-causing variant that explained the patient's clinical features. SAP scores were calculated, and the rank of the disease-causing variant was compared with a known method, Exomiser. Using the SAP score, the known causative variant was ranked in the top 10 retained variants for 94% (77 of 82) of the family-based exomes and in first place for 73% of these cases. For singleton exomes, the SAP score analysis ranked the known pathogenic variants within the top 10 for 80% (28 of 35) of cases. The SAP score, which is independent of detected variants, demonstrates comparable performance with Exomiser, which considers both phenotype and variant-level evidence simultaneously. Among 102 cases with negative results or variants of uncertain significance, SAP score analysis revealed two cases with a potential new diagnosis based on rank. The SAP score, a phenotypic quantitative metric, can be used in conjunction with standard variant filtration and annotation to enhance variant prioritization in exome analysis.</p></div>","PeriodicalId":50128,"journal":{"name":"Journal of Molecular Diagnostics","volume":"26 5","pages":"Pages 337-348"},"PeriodicalIF":3.4000,"publicationDate":"2024-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Molecular Diagnostics","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1525157824000291","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PATHOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Several in silico annotation-based methods have been developed to prioritize variants in exome sequencing analysis. This study introduced a novel metric Significance Associated with Phenotypes (SAP) score, which generates a statistical score by comparing an individual's observed phenotypes against existing gene–phenotype associations. To evaluate the SAP score, a retrospective analysis was performed on 219 exomes. Among them, 82 family-based and 35 singleton exomes had at least one disease-causing variant that explained the patient's clinical features. SAP scores were calculated, and the rank of the disease-causing variant was compared with a known method, Exomiser. Using the SAP score, the known causative variant was ranked in the top 10 retained variants for 94% (77 of 82) of the family-based exomes and in first place for 73% of these cases. For singleton exomes, the SAP score analysis ranked the known pathogenic variants within the top 10 for 80% (28 of 35) of cases. The SAP score, which is independent of detected variants, demonstrates comparable performance with Exomiser, which considers both phenotype and variant-level evidence simultaneously. Among 102 cases with negative results or variants of uncertain significance, SAP score analysis revealed two cases with a potential new diagnosis based on rank. The SAP score, a phenotypic quantitative metric, can be used in conjunction with standard variant filtration and annotation to enhance variant prioritization in exome analysis.

与表型相关的重要性(SAP)评分有助于确定外显子组测序分析的变异优先级。
为了在外显子测序分析中对变异进行优先排序,已经开发出了几种基于硅注释的方法。本研究引入了一种新的指标--与表型相关的重要性(Significance Associated with Phenotypes,SAP)评分,它通过比较个体观察到的表型与现有的基因-表型关联来生成统计评分。为了评估 SAP 评分,我们对 219 个外显子组进行了回顾性分析。其中,82个家族外显子和35个单体外显子中至少有一个致病变异能解释患者的临床特征。我们计算了 SAP 分数,并将致病变异的等级与已知方法 Exomiser 进行了比较。通过 SAP 评分,94%(77/82)的家族外显子组的已知致病变异体被排在保留变异体的前 10 位,其中 73% 的病例被排在第一位。对于单个外显子组,SAP 评分分析将 80% 的病例(28/35)中的已知致病变异排在前 10 位。SAP 评分与检测到的变异无关,其性能与同时考虑表型和变异水平证据的 Exomiser 不相上下。在 102 例结果为阴性或变异意义不确定的病例中,SAP 评分分析发现两例病例有可能根据等级做出新的诊断。SAP 评分是一种表型量化指标,可与标准变异筛选和注释结合使用,以提高外显子组分析中变异的优先级。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
8.10
自引率
2.40%
发文量
143
审稿时长
43 days
期刊介绍: The Journal of Molecular Diagnostics, the official publication of the Association for Molecular Pathology (AMP), co-owned by the American Society for Investigative Pathology (ASIP), seeks to publish high quality original papers on scientific advances in the translation and validation of molecular discoveries in medicine into the clinical diagnostic setting, and the description and application of technological advances in the field of molecular diagnostic medicine. The editors welcome for review articles that contain: novel discoveries or clinicopathologic correlations including studies in oncology, infectious diseases, inherited diseases, predisposition to disease, clinical informatics, or the description of polymorphisms linked to disease states or normal variations; the application of diagnostic methodologies in clinical trials; or the development of new or improved molecular methods which may be applied to diagnosis or monitoring of disease or disease predisposition.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信